SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Luminex Corp. LMNX -- Ignore unavailable to you. Want to Upgrade?


To: Hamilton Rogers who wrote (16)3/25/2000 10:46:00 PM
From: sam  Respond to of 47
 
From Raging Bull: fwiw

Luminex (LMNX)
Expected IPO date:
March 30
Proposed offering price:
$17-$19
Shares offered:
4.5 million
Offering amount:
$100 million
Post-offering shares:
26.5 million
Lead underwriter:
Warburg Dillon Read

Summary: The company developed and
manufactures the Luminex 100, a proprietary
technology platform used to simply perform nearly
100 biological tests for the life sciences industry.

Competitors: Endogen, Aurora Biosciences
(ABSC), LJL BioSystems (LJLB)

Revenue (year ended December 31): $3.1 million

Net income (year ended December 31): $8.4
million loss

ragingbull.com